Eyal Attar

Eyal Attar is a seasoned medical professional with significant experience in leadership roles within the biotechnology and pharmaceutical sectors. Currently serving as Chief Medical Officer at Halda Therapeutics since April 2025, Eyal has previously held similar roles at Vor Bio and Aprea Therapeutics. Prior experience includes the position of Senior Medical Director at Agios Pharmaceuticals and various clinical roles at prestigious institutions such as Harvard Medical School - Massachusetts General Hospital and Dana-Farber Cancer Institute. Eyal Attar completed a Chemistry degree at the University of North Carolina at Chapel Hill and earned a Doctor of Medicine from the UNC School of Medicine.